We came across a bullish thesis on CorMedix Inc. (CRMD) on Archetype Capital’s Substack. In this article, we will summarize ...

Tacrolimus has previously shown antipruritic action in atopic dermatitis, so researchers decided to investigate it for uremic pruritus.

In 1991, research nurse Karen Rapp was hired by the UC San Diego Stroke Center to oversee a new clinical trial. The goal: to ...

The Chief Medical Director of Abia State Specialist Hospital and Diagnostic Centre, Dr. Chimezie Okwuonu, has expressed concerns over the short survival rate of Nigerians diagnosed with kidney failure ...

Racial inequities in health care and research have long been a problem. Increasing the number of Black participants in ...

Accused in the shooting, which occurred one month after the brazen murder of the UnitedHealthcare CEO in New York City, was ...

McDevitt said his research found that when independent clinics are acquired by DaVita or Fresenius, their transplant referrals drop by about 10%, their patient survival rates fall by 2%, ...

Fresenius recently deconsolidated its Fresenius Medical Care division and now holds a 25% equity stake. As part of this deconsolidation, a significant portion of the company’s debt was also removed ...

Investigators successfully tested an acellular tissue engineered vessel for hemodialysis vascular access in patients at high-risk for arteriovenous fistula (AVF) maturation failure.

The late-breaking abstracts presented on the last day of the 2025 European Hematology Association (EHA) Congress show “what a vibrant clinical specialty we’re in,” according to session cochair Brian ...

The abstract titled “Acellular Tissue Engineered Vessel Outperforms Arteriovenous Fistula in High-Risk Patients on Hemodialysis: Results from the CLN-PRO-V007 Randomized Controlled Trial” will ...

Clinical trials to continue the development of a liver dialysis device to treat those with life-threatening liver disease have been funded by a grant awarded to UCL, the Royal Free Hospital and ...